유전성 대장암 = Hereditary Colorectal Cancer

국문 초록 (Abstract)

대장암은 우리나라에서 가장 급격하게 발생이 증가하는 암종의 하나로 유전성 대장암은 전체 대장암의 5-15%를 차지한다. 유전성 대장암은 크게 유전성 비용종증 대장암과 유전성 용종 증후군에서 발생하는 대장암으로 나눌 수 있고, 유전성 용종 증후군에는 가족성 용종증, 포이츠-예거 증후군, 유년기 용종증, MYH 연관 용종증 등이 이에 해당한다. 유전성 대장암은 원인 유전자의 배선돌연변이에 기인하므로 산발성 대장암에 비하여 암이 조기 발생하고, 동시성 및 이시성 암이 흔하며, 대장 이외의 장기에도 종양을 비롯한 질병을 일으키는 특징이 있다. 유전성 대장암은 환자뿐 아니라 가족구성원에 대한 유전자 검사, 유전 상담, 조기 진단을 위한 정기 검진이 매우 중요하며, 이러한 환자 및 가족구성원의 효율적 관리를 위한 유전성종양 등록소의 역할이 중요하다. 본 논문에서는 유전성 대장암에 해당하는 질환들의 임상적/유전적 특성, 치료, 유전자 검사 및 정기검진 프로그램에 대하여 고찰하고자 한다.

다국어 초록 (Multilingual Abstract)

Colorectal cancer is one of the most steeply increasing malignancies in Korea. Among 398,824 new patients recorded by the Korea Central Cancer Registry between 2003 and 2005, 47,915 cases involved colorectal cancers, accounting for 12.0 % of all malignancies. In 2002, total number of colorectal cancer cases had accounted for 11.2 % of all malignancies. Hereditary syndromes are the source of approximately 5% to 15% of overall colorectal cancer cases. Hereditary colorectal cancers are divided into two types: hereditary nonpolyposis colorectal cancer (HNPCC), and cancers associated with hereditary colorectal polyposis, including familial adenomatous polyposis (FAP), Peutz-Jeghers syndrome, juvenile polyposis, and the recently reported hMutYH (MYH)-associated polyposis (MAP). Hereditary colorectal cancers have unique clinical features distinct from sporadic cancer because these are due to germline mutations of the causative genes; (ⅰ) early age-of-onset of cancer, (ⅱ) frequent association with synchronous or metachronous tumors, (ⅲ) frequent association with extracolonic manifestations. The management strategy for patients with hereditary colorectal cancer is quite different from that for sporadic cancer. Furthermore, screening, genetic counseling, and surveillance for at-risk familial member are also important. A well-organized registry can plays a central role in the surveillance and management of families affected by hereditary colorectal cancers. Here, we discuss each type of hereditary colorectal cancer, focusing on the clinical and genetic characteristics, management, genetic screening, and surveillance.

목차 (Table of Contents)

• 서론
• 유전성 비용종증 대장암
• 가족성 용종증
• 포이츠-예거 증후군
• 유년기 용종증
• MYH 연관 용종증
• 유전성종양등록소의 역할
• 국문초록
• 참고문헌

참고문헌 (Reference)

1 Ionov Y, "Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis" 363 : 558-561, 1993

2 Ribic CM, "Tumor microsatelliteinstability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer" 349 : 247-257, 2003

3 Chung D, "The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications" 138 : 560-570, 2003

4 Schwartz RA, "The Muir-Torre syndrome:25 year retrospect" 33 : 90-104, 1995

5 Vasen HFA, "The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC)" 34 : 424-425, 1991

6 Park JG, "Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis" 42 : 710-715, 1999

7 Park JG, "Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study" 17 : 109-114, 2002

8 Olschwang S, "Somatically acquired genetic alterations in flat colorectal neoplasias" 77 : 366-369, 1998

9 Park YJ, "Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea" 6 : 2994-2998, 2000

10 Bulow S, "Results of national registration of familial adenomatous polyposis" 52 : 742-746, 2003

11 Winawer SJ, "Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup" 329 : 1977-1981, 1993

12 Jass JR, "Pathology of hereditary nonpolyposis colorectal cancer" 910 : 62-73, 2000

13 Vasen HFA, "New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC" 116 : 1453-1456, 1999

14 원영주, "Nationwide Cancer Incidence in Korea, 2003~2005" 대한암학회 41 (41): 122-131, 2009

15 Shin KH, "Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene" 62 : 38-42, 2002

16 Kim DW, "Mutation spectrum of the APC gene in 83 Korean FAP families" 26 : 281-281, 2005

17 Sieber OM, "Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH" 348 : 791-799, 2003

18 Mitchell J, "Mismatch repair genes hMLHI and hMSH2 and colorectal cancer: a HuGE review" 156 : 885-902, 2002

19 Muller A, "Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC)" 20 : 102-109, 2002

20 Peltomaki P, "Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome" 53 : 5853-5855, 1993

21 Parsons R, "Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer" 55 : 5548-5550, 1995

22 Heiskanen I, "Management of duodenal adenomas in 98 patients with familial adenomatous polyposis" 31 : 412-416, 1999

23 Gordon PH, "Malignant neoplasms of the colon. In:Gordon PH, Nivatvongs S, editors. Principles and Practice of Surgery for the Colon, Rectum, and Anus. 3rd ed" Informa Healthcare USA, Inc 489-644, 2006

24 Bodmer WF, "Localization of the gene for familial adenomatous polyposis on chromosome 5" 328 : 614-616, 1987

25 Aarnio M, "Lifetime risk of different cancers in hereditary nonpolyposis colorectal cancer" 64 : 430-433, 1995

26 Al-Tassan, "Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors" 30 : 227-232, 2002

27 Kim IJ, "Identification of a novel BMPR1A germline mutation in a Korean juvenile polyposis patient without SMAD4 mutation" 63 : 126-130, 2003

28 Rusin LC, "Hereditary nonpolyposis colorectal cancer. In: Wolff BG, Fleshman JW, Beck DE, editors. The ASCRS Textbook of Colon and Rectal Surgery. 1st ed" Springer 525-542, 2007

29 Jeong SY, "Hereditary cancer and genetic counseling" 4 : 15-21, 2007

30 Shin YK, "Germline mutationss in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families" 24 : 351-351, 2004

31 Kim DW, "Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas" 22 : 1173-1178, 2007

32 Won YJ, "Germline mutations of the APC gene in Korean familial adenomatous polyposis patients" 44 : 103-108, 1999

33 Park JG, "Germline mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer – InSiGHT Collaborative Study" 12 : 3389-3393, 2006

34 Shin KH, "Germline mutations in a polycytosine repeat of the hMSH6 gene in Korean hereditary nonpolyposis colorectal cancer" 44 : 18-21, 1999

35 Kim IJ, "Germline mutation of the dpc4 gene in Korean juvenile polyposis patients" 86 : 529-532, 2000

36 Calin G, "Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGFβ RII, BAX, hMSH3, hMSH6, IGFIIR, and BLM genes" 89 : 230-235, 2000

37 Burt RW, "Familial colorectal cancer:diagnosis and management. In: Young GP, Roger P, Leven B, eds. Prevention and Early Detection of Colorectal Cancer" WB Saunders 171-194, 1996

38 Park JG, "Familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer in Korea. In: Baba S, editor. New Strategies for Treatment of Hereditary Colorectal Cancer" Churchill Livingstone 1996

39 Bussey HJ, "Familial Polyposis Coli. Family Studies, Histopathology, Differential Diagnosis and Results of Treatment" Johns Hopkins University Press 1975

40 Groves CJ, "Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study" 50 : 636-641, 2002

41 Clark SK, "Desmoids in familial adenomatous polyposis" 83 : 1494-1504, 1996

42 Makinen MJ, "Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis" 193 : 286-294, 2001

43 Choi HS, "Clinical characteristics of Peutz-Jeghers syndrome in Korean polyposis patients" 15 : 35-38, 2000

44 Belchez LA, "Changing cause of mortality in patients with familial adenomatous polyposis" 39 : 387-387, 1996

45 Park JK, "COLOPROCTOLOGY. 3rd ed" Ilchokak 2006

46 Wagner A, "Atypical HNPCC owing to MSH6 germline mutations; analysis of a large Dutch pedigree" 58 : 318-322, 2001

47 Elsaleh H, "Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer" 355 : 1745-1750, 2000

48 Boland CR, "A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer" 58 : 5248-5257, 1998